Bayer AG ADR (BAYRY): Price and Financial Metrics
GET POWR RATINGS... FREE!
BAYRY Stock Price Chart Interactive Chart >
BAYRY Price/Volume Stats
|Current price||$15.70||52-week high||$18.45|
|Prev. close||$15.61||52-week low||$12.45|
|Day high||$15.87||Avg. volume||601,892|
|50-day MA||$16.76||Dividend yield||2.23%|
|200-day MA||$15.09||Market Cap||61.68B|
Bayer AG ADR (BAYRY) Company Bio
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University, Sensyne Health plc, and Atomwise Inc. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Most Popular Stories View All
BAYRY Latest News Stream
|Loading, please wait...|
BAYRY Latest Social Stream
View Full BAYRY Social Stream
Latest BAYRY News From Around the Web
Below are the latest news stories about Bayer Aktiengesellschaft that investors may wish to consider to help them evaluate BAYRY as an investment opportunity.
Whether you have a meticulous front lawn accented with shrubs and flowers — or a backyard garden filled with the promise of delicious tomatoes and peppers — dealing with weeds can feel like an impossible task.
Plant breeding today involves some of the world’s most sophisticated technologies and practices
A unit of Norwegian plant nutrition company Yara International ASA has acquired for an undisclosed sum a 14% stake in Brazilian online farm products trade platform Orbia, majority owned by Germany's Bayer AG. The move, formally announced after the parties secured approval from Brazilian antitrust authorities for the deal, comes as Yara aims to derive 25% of its sales from online channels by 2025, Yara Americas Vice President Cleiton Vargas said in an interview. "Orbia was a perfect fit," Vargas said.
Industry-leading investment expected to translate to nearly €30bn peak sales potential
BAYRY Price Returns
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|